TWST

Twist Bioscience Corporation

$159.85

+$14.60 (10.05%)Oct 27 close

Healthcare Compare Technicals

1M 3M 6M 1Y 2Y

TWSTSPY

Wall St. Highest PT $215.00 (+34.5%) Wall St. Avg PT $168.25 (+5.3%)

Underwater Drawdown %Max DD -35.2%Current -22.0%

Relative Strength vs SPY+354.1% vs SPYOutperforming

+$17.15 (12.02%)

−$22.98 (12.57%)

+$71.30 (80.52%)

+$100.70 (170.25%)

YTD

+$128.13 (403.94%)

+$125.67 (367.67%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar

Wall Street analyst consensus

Buy

12 analysts · mean score 1.92

1 = Strong Buy · 5 = Sell

Wall Street consensus

Analyst price targets

Current price$159.85

Average target$168.25

+$8.40 (+5.3%) upsideaverage target vs current price

CurrentAverageMedian

Low$45.00

Median$168.25

High$215.00

12-month Wall Street target range

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$9.3B

P/E (next 12 months, estimated)-349.8

52-week range$23.30 – $219.71

Revenue growth (latest quarter vs a year ago)+23.2%

Dividend yieldNo dividend

Analyst consensusBuy (12)

Average analyst price target$168.25 (+5%)

What they do

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. It offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage. It provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels.

Healthcare · Biotechnology

Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

No sector grades for TWST yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth

Outside this model's universe or screens

Momentum Top 15

Outside this model's universe or screens

Momentum Blend

Not in the current book

New Highs Growth

ranked 2 of 589 · 12-month momentum 414.8%

SURVYR. Barbell Momentum & T-Bill Shield

Outside this model's universe or screens

SURVYR. Physical AI Grid & Power

Outside this model's universe or screens

SURVYR. Long Book

Not in the current book

Earnings & events

TWST earningsNext report in 15 days

Next report

Thu Nov 12, 2026Before the open

EPS consensus-$0.20

Revenue consensus–

Last 4 quarters · EPS vs estimate

Aug 3, 2026-$0.56est -$0.28−98.5%Below estimates

May 4, 2026-$0.60est -$0.53−12.6%Below estimates

Feb 2, 2026-$0.50est -$0.52+3.9%Above estimates

Nov 14, 2025-$0.45est -$0.50+10.0%Above estimates

In line = within 1% of the estimate.

EstimateActual (beat)Actual (miss)

News & catalysts

More news

Surging Pharma Demand and Topline Beat Drive Twist Bioscience Corporation’s (TWST) Growth

Insider Monkey · 15h ago

Twist Bioscience Sinks 9%, Illumina Down 5% as AI and Genomics Stocks Slide

TIKR · Oct 22

Insider trades

Finn Patrick John

President and COO · 2026-10-23

Sell
$302.2K

Laponis Adam

Chief Financial Officer · 2026-10-09

Sell
$384.8K

Leproust Emily M.